Remote spatiotemporally controlled and biologically selective permeabilization of blood-brain barrier

Journal of Controlled Release

Volumn 217, Issue , 2015, Pages 113-120

  Xiong, Xiaobing ^a   Sun, Yao ^a   Sattiraju, Anirudh ^a   Jung, Youngkyoo ^a   Mintz, Akiva ^a   Hayasaka, Satoru ^a   Li, King C P ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Blood brain barrier; High intensity focused ultrasound; HSP70; Image guided drug delivery; MRI; Stem cells

Indexed keywords

AIR NAVIGATION; BLOOD; CELLS; CYTOLOGY; DIAGNOSIS; GENE EXPRESSION; MAGNETIC RESONANCE IMAGING; NEUROPHYSIOLOGY; STEM CELLS;

BLOOD-BRAIN BARRIER; CENTRAL NERVOUS SYSTEMS; CLINICAL TRANSLATION; HIGH INTENSITY FOCUSED ULTRASOUND; HSP70; IMAGE GUIDED DRUG DELIVERIES; INDUCIBLE GENE EXPRESSION; THERAPEUTIC AGENTS;

ENDOTHELIAL CELLS;

FIREFLY LUCIFERASE; GREEN FLUORESCENT PROTEIN; HEAT SHOCK PROTEIN 70; RED FLUORESCENT PROTEIN; TUMOR NECROSIS FACTOR ALPHA; LUCIFERASE; TUMOR NECROSIS FACTOR;

ADULT; ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; CELL ENGINEERING; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG PENETRATION; GENE EXPRESSION; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; HUMAN CELL; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; ROUS SARCOMA VIRUS; SPATIOTEMPORAL ANALYSIS; STEM CELL; ANIMAL; CELL CULTURE; GENE VECTOR; GENETICS; HEAT; HEK293 CELL LINE; LENTIVIRINAE; METABOLISM; MOUSE; NUDE RAT; PERMEABILITY; TRANSGENE; ULTRASOUND THERAPY;

ANIMALS; BLOOD-BRAIN BARRIER; CELLS, CULTURED; GENE EXPRESSION; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HEK293 CELLS; HOT TEMPERATURE; HSP70 HEAT-SHOCK PROTEINS; HUMANS; LENTIVIRUS; LUCIFERASES; MAGNETIC RESONANCE IMAGING; MALE; MICE; PERMEABILITY; RATS, NUDE; STEM CELLS; TRANSGENES; TUMOR NECROSIS FACTOR-ALPHA; ULTRASONIC THERAPY;

EID: 84940978184     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2015.08.044     Document Type: Article

References (54)

1. N.J. Abbott, L. Ronnback, and E. Hansson Astrocyte-endothelial interactions at the blood-brain barrier Nat Rev Neurosci 7 2006 41 53
2. N.J. Abbott, A.A.K. Patabendige, D.E.M. Dolman, S.R. Yusof, and D.J. Begley Structure and function of the blood-brain barrier Neurobiol Dis 37 2010 13 25
3. R.H. Edwards Drug delivery via the blood-brain barrier Nat Neurosci 4 2001 221 222
4. W.M. Pardridge The blood-brain barrier: bottleneck in brain drug development NeuroRx 2 2005 3 14
5. R.A. Kroll, and E.A. Neuwelt Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means Neurosurgery 42 1998 1083 1099
6. E. Neuwelt, N. Abbott, L. Abrey, W.A. Banks, B. Blakley, T. Davis, B. Engelhardt, P. Grammas, M. Nedergaard, J. Nutt, W. Pardridge, G.A. Rosenberg, Q. Smith, and L.R. Drewes Strategies to advance translational research into brain barriers Lancet Neurol 7 2008 84 96
7. K. Ulbrich, T. Knobloch, and J. Kreuter Targeting the insulin receptor: nanoparticles for drug delivery across the blood-brain barrier (BBB) J Drug Target 19 2011 125 132
8. S.I. Rapoport, and P.J. Robinson Tight-junctional modification as the basis of osmotic opening of the blood-brain-barrier Ann NY Acad Sci 481 1986 250 267
9. S.I. Rapoport Advances in osmotic opening of the blood-brain barrier to enhance CNS chemotherapy Expert Opin Inv Drug 10 2001 1809 1818
10. M.A. Bellavance, M. Blanchette, and D. Fortin Recent advances in blood-brain barrier disruption as a CNS delivery strategy AAPS J 10 2008 166 177
11. D.M. Robertson, J.J. Raymond, and H.B. Dinsdale Pharmacological modification of bradykinin induced breakdown of the blood-brain-barrier Can J Neurol Sci 13 1986 214 220
12. K. Matsukado, T. Inamura, S. Nakano, M. Fukui, R.T. Bartus, and K.L. Black Enhanced tumor uptake of carboplatin and survival in glioma-bearing rats by intracarotid infusion of bradykinin analog, RMP-7 - Neurosurgery 39 1996 125 133
13. M.D. Prados, S.C. Schold, H.A. Fine, K. Jaeckle, F. Hochberg, L. Mechtler, M.R. Fetell, S. Phuphanich, L. Feun, T.J. Janus, K. Ford, and W. Graney A randomized, double-blind, placebo-controlled, phase 2 study of RMP-7 in combination with carboplatin administered intravenously for the treatment of recurrent malignant glioma Neuro Oncol 5 2003 96 103
14. A.J. Carman, J.H. Mills, A. Krenz, D.G. Kim, and M.S. Bynoe Adenosine receptor signaling modulates permeability of the blood-brain barrier J Neurosci 31 2011 13272 13280
15. M.A. O'Reilly, A.C. Waspe, R. Chopra, and K. Hynynen MRI-guided disruption of the blood-brain barrier using transcranial focused ultrasound in a rat model J Vis Exp 61 2012 e3555
16. S. Dromi, V. Frenkel, A. Luk, B. Traughber, M. Angstadt, M. Bur, J. Poff, J. Xie, S.K. Libutti, K.C. Li, and B.J. Wood Pulsed-high intensity focused ultrasound and low temperature-sensitive liposomes for enhanced targeted drug delivery and antitumor effect Clin Cancer Res 13 2007 2722 2727
17. A.B. Etame, R.J. Diaz, C.A. Smith, T.G. Mainprize, K. Hynynen, and J.T. Rutka Focused ultrasound disruption of the blood-brain barrier: a new frontier for therapeutic delivery in molecular neurooncology Neurosurg Focus 32 2012 E3
18. M.A. O'Reilly, and K. Hynynen Ultrasound enhanced drug delivery to the brain and central nervous system Int J Hyperthermia 28 2012 386 396
19. K. Hynynen Ultrasound for drug and gene delivery to the brain Adv Drug Deliv Rev 60 2008 1209 1217
20. P. Sozio, L.S. Cerasa, A. Abbadessa, and A. Di Stefano Designing prodrugs for the treatment of Parkinson's disease Expert Opin Drug Dis 7 2012 385 406
21. H.L. Wong, X.Y. Wu, and R. Bendayan Nanotechnological advances for the delivery of CNS therapeutics Adv Drug Deliv Rev 64 2012 686 700
22. S.A. Stanley, J. Sauer, R.S. Kane, J.S. Dordick, and J.M. Friedman Remote regulation of glucose homeostasis in mice using genetically encoded nanoparticles Nat Med 21 2015 92 98
23. L.R. Polstein, and C.A. Gersbach Light-inducible spatiotemporal control of gene activation by customizable zinc finger transcription factors J Am Chem Soc 134 2012 16480 16483
24. S. Konermann, M.D. Brigham, A.E. Trevino, P.D. Hsu, M. Heidenreich, L. Cong, R.J. Platt, D.A. Scott, G.M. Church, and F. Zhang Optical control of mammalian endogenous transcription and epigenetic states Nature 500 2013 472 476
25. O.F. Eker, B. Quesson, C. Rome, J. Arsaut, C. Deminiere, C.T. Moonen, N. Grenier, and F. Couillaud Combination of cell delivery and thermoinducible transcription for in vivo spatiotemporal control of gene expression: a feasibility study Radiology 258 2011 496 504
26. R. Deckers, B. Quesson, J. Arsaut, S. Eimer, F. Couillaud, and C.T.W. Moonen Image-guided, noninvasive, spatiotemporal control of gene expression Proc Natl Acad Sci U S A 106 2009 1175 1180
27. C. Rome, F. Couillaud, and C.T.W. Moonen Spatial and temporal control of expression of therapeutic genes using heat shock protein promoters Methods 35 2005 188 198
28. Z. Ram, Z.R. Cohen, S. Harnof, S. Tal, M. Faibel, D. Nass, and S.E. Maier Magnetic resonance imaging-guided, high-intensity focused ultrasound for brain tumor therapy Neurosurgery 59 2006 949 955
29. F.A. Jolesz, and N.J. McDannold Magnetic resonance-guided focused ultrasound a new technology for clinical neurosciences Neurol Clin 32 2014 253 269
30. K. Hynynen, and J. Sun Trans-skull ultrasound therapy: the feasibility of using image-derived skull thickness information to correct the phase distortion IEEE Trans Ultrason Ferroelectr Freq Control 46 1999 752 755
31. R.M. Dwyer, S. Khan, F.P. Barry, T. O'Brien, and M.J. Kerin Advances in mesenchymal stem cell-mediated gene therapy for cancer Stem Cell Res Ther 1 2010
32. D.A. Robinton, and G.Q. Daley The promise of induced pluripotent stem cells in research and therapy Nature 481 2012 295 305
33. S. Kidd, E. Spaeth, J.L. Dembinski, M. Dietrich, K. Watson, A. Klopp, V.L. Battula, M. Weil, M. Andreeff, and F.C. Marini Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imaging Stem Cells 27 2009 2614 2623
34. S.U. Kim, and J. de Vellis Stem cell-based cell therapy in neurological diseases: a review J Neurosci Res 87 2009 2183 2200
35. W.A. Zhao, D.G. Phinney, D. Bonnet, M. Dominici, and M. Krampera Mesenchymal stem cell biodistribution, migration, and homing in vivo Stem Cells Int 2014 2014 292109
36. R.D. Peters, R.S. Hinks, and R.M. Henkelman Ex vivo tissue-type independence in proton-resonance frequency shift MR thermometry Magn Reson Med 40 1998 454 459
37. K. Shah Mesenchymal stem cells engineered for cancer therapy Adv Drug Deliv Rev 64 2012 739 748
38. A. Malgieri, E. Kantzari, M.P. Patrizi, and S. Gambardella Bone marrow and umbilical cord blood human mesenchymal stem cells: state of the art Int J Clin Exp Med 3 2010 248 269
39. J.M. Karp, and G.S.L. Teol Mesenchymal stem cell homing: the devil is in the details Cell Stem Cell 4 2009 206 216
40. J. Ankrum, and J.M. Karp Mesenchymal stem cell therapy: two steps forward, one step back Trends Mol Med 16 2010 203 209
41. O. Levy, W.A. Zhao, L.J. Mortensen, S. LeBlanc, K. Tsang, M.Y. Fu, J.A. Phillips, V. Sagar, P. Anandakumaran, J. Ngai, C.H. Cui, P. Eimon, M. Angel, C.P. Lin, M.F. Yanik, and J.M. Karp mRNA-engineered mesenchymal stem cells for targeted delivery of interleukin-10 to sites of inflammation Blood 122 2013 E23 E32
42. S.K. Kang, I.S. Shin, M.S. Ko, J.Y. Jo, and J.C. Ra Journey of mesenchymal stem cells for homing: strategies to enhance efficacy and safety of stem cell therapy Stem Cells Int 2012 2012 342968
43. H. Naderi-Meshkin, A.R. Bahrami, H.R. Bidkhori, M. Mirahmadi, and N. Ahmadiankia Strategies to improve homing of mesenchymal stem cells for greater efficacy in stem cell therapy Cell Biol Int 39 2015 23 34
44. F. Balkwill Tumour necrosis factor and cancer Nat Rev Cancer 9 2009 361 371
45. F.J. Lejeune High dose recombinant tumour necrosis factor (rTNF alpha) administered by isolation perfusion for advanced tumours of the limbs: a model for biochemotherapy of cancer Eur J Cancer 31A 1995 1009 1016
46. T. Seki, F. Carroll, S. Illingworth, N. Green, R. Cawood, H. Bachtarzi, V. Subr, K.D. Fisher, and L.W. Seymour Tumour necrosis factor-alpha increases extravasation of virus particles into tumour tissue by activating the Rho A/Rho kinase pathway J Control Release 156 2011 381 389
47. G.Y. Yang, C. Gong, Z. Qin, X.H. Liu, and A. Lorris Betz Tumor necrosis factor alpha expression produces increased blood-brain barrier permeability following temporary focal cerebral ischemia in mice Brain Res Mol Brain Res 69 1999 135 143
48. J.J. Connell, G. Chatain, B. Cornelissen, K.A. Vallis, A. Hamilton, L. Seymour, D.C. Anthony, and N.R. Sibson Selective permeabilization of the blood-brain barrier at sites of metastasis J Natl Cancer Inst 105 2013 1634 1643
49. N. Tsao, H.P. Hsu, C.M. Wu, C.C. Liu, and H.Y. Lei Tumour necrosis factor-alpha causes an increase in blood-brain barrier permeability during sepsis J Med Microbiol 50 2001 812 821
50. W. Hundt, C. Schink, S. Steinbach, C.E. O'Connell-Rodwell, D. Mayer, M. Burbelko, A. Kiessling, and S. Guccione Use of in vivo bioluminescence and MRI to determine hyperthermia-induced changes in luciferase activity under the control of an hsp70 promoter NMR Biomed 25 2012 1378 1391
51. K.R. Diller Stress protein expression kinetics Annu Rev Biomed Eng 8 2006 403 424
52. N. McDannold, N. Vykhodtseva, F.A. Jolesz, and K. Hynynen MRI investigation of the threshold for thermally induced blood-brain barrier disruption and brain tissue damage in the rabbit brain Magn Reson Med 51 2004 913 923
53. M. Diaz-Coranguez, J. Segovia, A. Lopez-Ornelas, H. Puerta-Guardo, J. Ludert, B. Chavez, N. Meraz-Cruz, and L. Gonzalez-Mariscal Transmigration of neural stem cells across the blood brain barrier induced by glioma cells PLoS One 8 2013 e60655
54. K.S. Aboody, A. Brown, N.G. Rainov, K.A. Bower, S. Liu, W. Yang, J.E. Small, U. Herrlinger, V. Ourednik, P.M. Black, X.O. Breakefield, and E.Y. Snyder Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas Proc Natl Acad Sci U S A 97 2000 12846 12851